Transfusion immunomodulation from a clinical perspective: An update

Expert Review of Hematology

Volumn 6, Issue 6, 2013, Pages 653-663

  Refaai, Majed A ^a   Blumberg, Neil ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Allogeneic transfusion; Immunomodulation; Leukoreduction; Storage lesions; Transfusion; Transfusion complication

Indexed keywords

CD40 LIGAND; GAMMA INTERFERON; HLA A ANTIGEN; HLA B ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE FRAGMENT; PHOSPHATIDYLSERINE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIGEN PRESENTATION; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BLOOD COMPONENT; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CANCER RECURRENCE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EFFECTOR CELL; ERYTHROCYTE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; MACROPHAGE; MACROPHAGE FUNCTION; MIXED LYMPHOCYTE CULTURE; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; NONHUMAN; PHAGOCYTE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SUPPRESSOR CELL; THROMBOCYTE; THROMBOCYTE TRANSFUSION; TRANSFUSION RELATED ACUTE LUNG INJURY; UPREGULATION; WOUND HEALING;

BLOOD TRANSFUSION; COMMUNICABLE DISEASES; HUMANS; IMMUNE SYSTEM; IMMUNOMODULATION; NEOPLASMS; RECURRENCE; T-LYMPHOCYTES;

EID: 84887967630     PISSN: 17474086     EISSN: 17474094     Source Type: Journal    
DOI: 10.1586/17474086.2013.850026     Document Type: Review

References (97)

1. Blumberg N, Heal JM. Immunomodulation by blood transfusion: An evolving scientific and clinical challenge. Am. J. Med. 101(3), 299-308 (1996
2. Blajchman MA. Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: Do we have the answers yet? Transfusion 37(2), 121-125 (1997
3. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant. Proc. 5(1), 253-259 (1973
4. Blumberg N, Agarwal MM, Chuang C. Relation between recurrence of cancer of the colon and blood transfusion. Br. Med. J. (Clin. Res. Ed.) 290(6474), 1037-1039 (1985
5. Burrows L, Tartter P. Effect of blood transfusions on colonic malignancy recurrent rate. Lancet 2(8299), 662 (1982
6. Tartter PI, Driefuss RM, Malon AM, Heimann TM, Aufses AH. Relationship of postoperative septic complications and blood transfusions in patients with Crohn's disease. Am. J. Surg.155(1), 43-48 (1988
7. Opelz G, Terasaki PI. Poor kidney-Transplant survival in recipients with frozen-blood transfusions or no transfusions. Lancet 2(7882), 696-698 (1974
8. Jensen LS, Andersen AJ, Christiansen PM et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br. J. Surg. 79(6), 513-516 (1992
9. Murphy P, Heal JM, Blumberg N. Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion 31(3), 212-217 (1991
10. van der Mast BJ, Balk AH. Effect of HLA-DR-shared blood transfusion on the clinical outcome of heart transplantation. Transplantation 63(10), 1514-1519 (1997
11. Ferńandez FG, Jaramillo A, Ewald G et al. Blood transfusions decrease the incidence of acute rejection in cardiac allograft recipients. J. Heart Lung Transplant. 24(7 Suppl.), S255-S261 (2005
12. Blumberg N, Heal JM. Effects of transfusion on immune function. Cancer recurrence and infection. Arch. Pathol. Lab. Med. 118(4), 371-379 (1994
13. Duffy G, Neal KR. Differences in post-operative infection rates between patients receiving autologous and allogeneic blood transfusion: A meta-Analysis of published randomized and nonrandomized studies. Transfus. Med. 6(4), 325-328 (1996
14. Francis DM, Shenton BK. Blood transfusion and tumour growth: Evidence from laboratory animals. Lancet 2(8251), 871 (1981
15. van de Watering LM, Hermans J, Houbiers JG et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: A randomized clinical trial. Circulation 97(6), 562-568 (1998
16. Lannan KL, Sahler J, Spinelli SL, Phipps RP, Blumberg N. Transfusion immunomodulation-The case for leukoreduced and (perhaps) washed transfusions. Blood Cells Mol. Dis. 50(1), 61-68 (2013
17. Kirkley SA, Cowles J, Pellegrini VD, Harris CM, Boyd AD, Blumberg N. Cytokine secretion after allogeneic or autologous blood transfusion. Lancet 345(8948), 527 (1995
18. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045 (1994
19. Williams JG, Hughes LE. Effect of perioperative blood transfusion on recurrence of Crohn's disease. Lancet 2(8678-8679), 1524 (1989
20. van der Horst-Bruinsma IE, Huizinga TW, Lagaay EM et al. The influence of a partially HLA-matched blood transfusion on the disease activity of rheumatoid arthritis. Rheumatology (Oxford) 38(1), 53-58 (1999
21. Scott AD, Ritchie JK, Phillips RK. Blood transfusion and recurrent Crohn's disease. Br. J. Surg. 78(4), 455-458 (1991
22. Baumgartner JM, Silliman CC, Moore EE, Banerjee A, McCarter MD. Stored red blood cell transfusion induces regulatory T cells. J. Am. Coll. Surg. 208(1), 110-119 (2009
23. Bushell A, Karim M, Kingsley CI, Wood KJ. Pretransplant blood transfusion without additional immunotherapy generates CD25+CD4+ regulatory T cells: A potential explanation for the blood-Transfusion effect. Transplantation 76(3), 449-455 (2003
24. Golub R, Golub RW, Cantu R, Stein HD. A multivariate analysis of factors contributing to leakage of intestinal anastomoses. J. Am. Coll. Surg. 184(4), 364-372 (1997
25. Mowbray JF, Gibbings C, Liddell H, Reginald PW, Underwood JL, Beard RW. Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet 1(8435), 941-943 (1985
26. Raghupathy R, Makhseed M, Azizieh F, Omu A, Gupta M, Farhat R. Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum. Reprod. 15(3), 713-718 (2000
27. Preiksaitis JK, Brown L, McKenzie M. The risk of cytomegalovirus infection in seronegative transfusion recipients not receiving exogenous immunosuppression. J. Infect. Dis. 157(3), 523-529 (1988
28. Cerhan JR, Wallace RB, Dick F et al. Blood transfusions and risk of non-Hodgkin's lymphoma subtypes and chronic lymphocytic leukemia. Cancer Epidemiol. Biomarkers Prev. 10(4), 361-368 (2001
29. Blajchman MA, Bardossy L, Carmen R, Sastry A, Singal DP. Allogeneic blood transfusion-induced enhancement of tumor growth: Two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood 81(7), 1880-1882 (1993
30. Vanderlinde ES, Heal JM, Blumberg N. Autologous transfusion. BMJ 324(7340), 772-775 (2002
31. Kaliss N, Snell GD. The effects of injections of lyophilized normal and neoplastic mouse tissues on the growth of tumor homiotransplants in mice. Cancer Res. 11(2), 122-126 (1951
32. Little AG, Wu HS, Ferguson MK et al. Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer. Am. J. Surg. 160(6), 630-632; discussion 633 (1990
33. Heiss MM, Mempel W, Delanoff C et al. Blood transfusion-modulated tumor recurrence: First results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J. Clin. Oncol. 12(9), 1859-1867 (1994
34. Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N. Engl. J. Med. 328(19), 1372-1376 (1993
35. Blumberg N, Heal JM, Murphy P, Agarwal MM, Chuang C. Association between transfusion of whole blood and recurrence of cancer. Br. Med. J. (Clin. Res. Ed.) 293(6546), 530-533 (1986
36. Bordin JO, Bardossy L, Blajchman MA. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: The importance of the timing of the leukodepletion. Blood 84(1), 344-348 (1994
37. Hotchkiss RS, Chang KC, Grayson MH et al. Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc. Natl Acad. Sci. USA 100(11), 6724-6729 (2003
38. Gao Y, Herndon JM, Zhang H, Griffith TS, Ferguson TA. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J. Exp. Med. 188(5), 887-896 (1998
39. Mortensen FV, Jensen LS, Sørensen HT, Pedersen L. Cause-specific mortality associated with leukoreduced, buffy coat-depleted, or no blood transfusion after elective surgery for colorectal cancer: A posttrial 15-year follow-up study. Transfusion 51(2), 259-263 (2011
40. Blumberg N, Heal JM, Rowe JM A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440]. BMC Blood Disord. 4(1), 6 (2004
41. Triulzi DJ, Blumberg N, Heal JM. Association of transfusion with postoperative bacterial infection. Crit. Rev. Clin. Lab. Sci. 28(2), 95-107 (1990
42. Triulzi DJ, Vanek K, Ryan DH, Blumberg N. A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion 32(6), 517-524 (1992
43. Jensen LS, Andersen A, Fristrup SC et al. Comparison of one dose versus three doses of prophylactic antibiotics, and the influence of blood transfusion, on infectious complications in acute and elective colorectal surgery. Br. J. Surg. 77(5), 513-518 (1990
44. Gianotti L, Pyles T, Alexander JW, Fukushima R, Babcock GF. Identification of the blood component responsible for increased susceptibility to gut-derived infection. Transfusion 33(6), 458-465 (1993
45. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 348(9031), 841-845 (1996
46. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 84(6), 1703-1721 (1994
47. Mincheff MS, Meryman HT, Kapoor V, Alsop P, Wötzel M. Blood transfusion and immunomodulation: A possible mechanism. Vox Sang. 65(1), 18-24 (1993
48. Krensky AM, Clayberger C. Immunologic tolerance: Tailored antigen. Transplant. Proc. 28(4), 2075-2077 (1996
49. Phipps RP, Kaufman J, Blumberg N. Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet 357(9273), 2023-2024 (2001
50. Henn V, Slupsky JR, Grafe M et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391(6667), 591-594 (1998
51. Banks RE, Forbes MA, Kinsey SE et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology. Br. J. Cancer 77(6), 956-964 (1998
52. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood 105(6), 2266-2273 (2005
53. Saas P, Angelot F, Bardiaux L, Seilles E, Garnache-Ottou F, Perruche S. Phosphatidylserine-expressing cell by-products in transfusion: A pro-inflammatory or an anti-inflammatory effect? Transfus. Clin. Biol. 19(3), 90-97 (2012
54. Dzik S, Mincheff M, Puppo F. Apoptosis, transforming growth factor-beta, and the immunosuppressive effect of transfusion. Transfusion 42(9), 1221-1223 (2002
55. Gafter U, Kalechman Y, Sredni B. Blood transfusion enhances production of T-helper-2 cytokines and transforming growth factor beta in humans. Clin. Sci. (Lond.) 91(4), 519-523 (1996
56. Heiss MM, Fasol-Merten K, Allgayer H et al. Influence of autologous blood transfusion on natural killer and lymphokine-Activated killer cell activities in cancer surgery. Vox Sang. 73(4), 237-245 (1997
57. Jensen LS, Hokland M, Nielsen HJ. A randomized controlled study of the effect of bedside leucocyte depletion on the immunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery. Br. J. Surg. 83(7), 973-977 (1996
58. Nielsen HJ, Hammer JH, Moesgaard F, Kehlet H. Comparison of the effects of SAG-M and whole-blood transfusions on postoperative suppression of delayed hypersensitivity. Can. J. Surg. 34(2), 146-150 (1991
59. Shelby J, Marushack MM, Nelson EW. Prostaglandin production and suppressor cell induction in transfusion-induced immune suppression. Transplantation 43(1), 113-116 (1987
60. Dallman MJ, Wood KJ, Morris PJ. Recombinant interleukin-2 (IL-2) can reverse the blood transfusion effect. Transplant. Proc. 21(1 Pt 1), 1165-1167 (1989
61. Blumberg N, Heal JM. The transfusion immunomodulation theory: The Th1/ Th2 paradigm and an analogy with pregnancy as a unifying mechanism. Semin. Hematol. 33(4), 329-340 (1996
62. Goodnough LT, Shander A, Spence R. Bloodless medicine: Clinical care without allogeneic blood transfusion. Transfusion 43(5), 668-676 (2003
63. Bilgin YM, van de Watering LM, Eijsman L et al. Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation 109(22), 2755-2760 (2004
64. Bennett-Guerrero E, Zhao Y, O'Brien SM et al. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA 304(14), 1568-1575 (2010
65. Carson JL, Carless PA, Hébert PC. Outcomes using lower vs higher hemoglobin thresholds for red blood cell transfusion. JAMA 309(1), 83-84 (2013
66. Villanueva C, Colomo A, Bosch A et al. Transfusion strategies for acute upper gastrointestinal bleeding. N. Engl. J. Med. 368(1), 11-21 (2013
67. Goswami S, Brady JE, Jordan DA, Li G. Intraoperative cardiac arrests in adults undergoing noncardiac surgery: Incidence, risk factors, and survival outcome. Anesthesiology 117(5), 1018-1026 (2012
68. Wang D, Sun J, Solomon SB, Klein HG, Natanson C. Transfusion of older stored blood and risk of death: A meta-Analysis. Transfusion 52(6), 1184-1195 (2012
69. Lacroix J, Hébert P, Fergusson D et al. The Age of Blood Evaluation (ABLE) randomized controlled trial: Study design. Transfus. Med. Rev. 25(3), 197-205 (2011
70. Lee TH, Paglieroni T, Ohto H, Holland PV, Busch MP. Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: Frequent long-Term microchimerism in severe trauma patients. Blood 93(9), 3127-3139 (1999
71. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N. Engl. J. Med. 337(26), 1861-1869 (1997
72. Krailadsiri P, Seghatchian J, Macgregor I et al. The effects of leukodepletion on the generation and removal of microvesicles and prion protein in blood components. Transfusion 46(3), 407-417 (2006
73. Silliman CC, Moore EE, Kelher MR, Khan SY, Gellar L, Elzi DJ. Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion 51(12), 2549-2554 (2011
74. Blumberg N, Heal JM, Gettings KF et al. An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-Associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion 50(12), 2738-2744 (2010
75. Blumberg N, Zhao H, Wang H, Messing S, Heal JM, Lyman GH. The intention-To-Treat principle in clinical trials and meta-Analyses of leukoreduced blood transfusions in surgical patients. Transfusion 47(4), 573-581 (2007
76. Romano G, Mastroianni C, Bancone C et al. Leukoreduction program for red blood cell transfusions in coronary surgery: Association with reduced acute kidney injury and in-hospital mortality. J. Thorac. Cardiovasc. Surg. 140(1), 188-195 (2010
77. Plurad D, Belzberg H, Schulman I et al. Leukoreduction is associated with a decreased incidence of late onset acute respiratory distress syndrome after injury. Am. Surg. 74(2), 117-123 (2008
78. Netzer G, Shah CV, Iwashyna TJ et al. Association of RBC transfusion with mortality in patients with acute lung injury. Chest 132(4), 1116-1123 (2007
79. Miyaji K, Miyamoto T, Kohira S et al. The effectiveness of prestorage leukocyte-reduced red blood cell transfusion on perioperative inflammatory response with a miniaturized biocompatible bypass system. J. Thorac. Cardiovasc. Surg. 139(6), 1561-1567 (2010
80. Fung MK, Rao N, Rice J, Ridenour M, Mook W, Triulzi DJ. Leukoreduction in the setting of open heart surgery: A prospective cohort-controlled study. Transfusion 44(1), 30-35 (2004
81. Chang H, Hall GA, Geerts WH, Greenwood C, McLeod RS, Sher GD. Allogeneic red blood cell transfusion is an independent risk factor for the development of postoperative bacterial infection. Vox Sang. 78(1), 13-18 (2000
82. Penn I. The occurrence of malignant tumors in immunosuppressed states. Prog. Allergy 37, 259-300 (1986
83. Murphy MF. New variant Creutzfeldt-Jakob disease (nvCJD): The risk of transmission by blood transfusion and the potential benefit of leukocyte-reduction of blood components. Transfus. Med. Rev. 13(2), 75-83 (1999
84. Blumberg N, Heal JM, Gettings KF. WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization. Transfusion 43(7), 945-952 (2003
85. Hébert PC, Fergusson D, Blajchman MA et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA 289(15), 1941-1949 (2003
86. Hendrickson JE, Hillyer CD. Noninfectious serious hazards of transfusion. Anesth. Analg. 108(3), 759-769 (2009
87. Blumberg N, Heal JM, Cowles JW et al. Leukocyte-reduced transfusions in cardiac surgery results of an implementation trial. Am. J. Clin. Pathol. 118(3), 376-381 (2002
88. Llewelyn CA, Taylor RS, Todd AA et al. The effect of universal leukoreduction on postoperative infections and length of hospital stay in elective orthopedic and cardiac surgery. Transfusion 44(4), 489-500 (2004
89. Fergusson D, Hébert PC, Lee SK et al. Clinical outcomes following institution of universal leukoreduction of blood transfusions for premature infants. JAMA 289(15), 1950-1956 (2003
90. Baron JF, Gourdin M, Bertrand M et al. The effect of universal leukodepletion of packed red blood cells on postoperative infections in high-risk patients undergoing abdominal aortic surgery. Anesth. Analg. 94(3), 529-537; table of contents (2002
91. Dzik WH, Anderson JK, O'Neill EM, Assmann SF, Kalish LA, Stowell CP. A prospective, randomized clinical trial of universal WBC reduction. Transfusion 42(9), 1114-1122 (2002
92. Fergusson D, Khanna MP, Tinmouth A, Hébert PC. Transfusion of leukoreduced red blood cells may decrease postoperative infections: Two meta-Analyses of randomized controlled trials. Can. J. Anaesth. 51(5), 417-424 (2004
93. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-Associated immunomodulation: Fact or fictioñ. Blood 97(5), 1180-1195 (2001
94. Seghatchian J. Platelet storage lesion: An update on the impact of various leukoreduction processes on the biological response modifiers. Transfus. Apher. Sci. 34(1), 125-130 (2006
95. Moore FA, Moore EE, Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch. Surg. 132(6), 620-624; discussion 624-625 (1997
96. Blumberg N. Deleterious clinical effects of transfusion immunomodulation: Proven beyond a reasonable doubt. Transfusion 45 (2 Suppl.), 33S-39S; discussion 39S-40S (2005
97. Anderson KC, Ness PM. Scientific Basis of Transfusion Medicine : Implications for Clinical Practice. W.B. Saunders, Philadelphia (2000